BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 17403828)

  • 1. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory monitoring of OxyContin (oxycodone): clinical pitfalls.
    Von Seggern RL; Fitzgerald CP; Adelman LC; Adelman JU
    Headache; 2004 Jan; 44(1):44-7. PubMed ID: 14979882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'False-positive' and 'false-negative' test results in clinical urine drug testing.
    Reisfield GM; Goldberger BA; Bertholf RL
    Bioanalysis; 2009 Aug; 1(5):937-52. PubMed ID: 21083064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache.
    Schuckman H; Hazelett S; Powell C; Steer S
    Subst Use Misuse; 2008; 43(5):589-95. PubMed ID: 18393078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced urine toxicology testing.
    Tenore PL
    J Addict Dis; 2010 Oct; 29(4):436-48. PubMed ID: 20924879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.
    Pesce A; West C; Gonzales E; Rosenthal M; West R; Mikel C; Almazan P; Latyshev S; Horn P
    Pain Physician; 2012; 15(5):E687-92. PubMed ID: 22996862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The false positive reaction of the Triage panel drug-of-abuse by herbal drugs ma-huang (Ephedra sinica (Ephedraceae))].
    Nishiguchi M; Kinoshita H; Higasa K; Taniguchi T; Ouchi H; Minami T; Marukawa S; Yoshinaga K; Yamauchi J; Aoki S; Hishida S
    Nihon Hoigaku Zasshi; 2001 Nov; 55(3):331-8. PubMed ID: 11905042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory tests for rapid screening of drugs of abuse in the workplace: a review.
    Schwartz RH; Clark HW; Meek PS
    J Addict Dis; 1993; 12(2):43-56. PubMed ID: 8476942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of very low-cost contingency management in a community adolescent treatment program.
    Lott DC; Jencius S
    Drug Alcohol Depend; 2009 Jun; 102(1-3):162-5. PubMed ID: 19250774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of current clinical diagnosis in recreational drug-related attendance to the emergency department.
    West E; Cameron P; O'Reilly G; Drummer OH; Bystrzycki A
    Emerg Med Australas; 2008 Aug; 20(4):333-8. PubMed ID: 18782207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the drug-positive adolescent trauma population: should we, do we, and does it make a difference if we test?
    Ehrlich PF; Brown JK; Drongowski R
    J Pediatr Surg; 2006 May; 41(5):927-30. PubMed ID: 16677885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs of abuse testing in a psychiatric outpatient service.
    Shearer DS; Baciewicz GJ; Kwong TC
    Clin Lab Med; 1998 Dec; 18(4):713-26. PubMed ID: 9891610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit drug and alcohol users admitted to the pediatric emergency department.
    Kozer E; Bar-Hamburger R; Rosenfeld NY; Zdanovitch I; Bulkowstein M; Berkovitch M
    Isr Med Assoc J; 2008 Nov; 10(11):779-82. PubMed ID: 19070286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.